Option Care Health beats Q2 estimates with 15.4% revenue growth

Published 30/07/2025, 13:22
 Option Care Health beats Q2 estimates with 15.4% revenue growth

BANNOCKBURN, Ill. - Option Care Health, Inc. (NASDAQ:OPCH), the nation’s largest independent provider of home and alternate site infusion services, reported second quarter earnings that exceeded analyst expectations, with revenue climbing 15.4% YoY to $1.42 billion, above the consensus estimate of $1.35 billion.

The company posted adjusted earnings per share of $0.41, beating analyst estimates of $0.38. Revenue growth was driven by strong performance across its infusion services, with total revenue reaching $1.42 billion compared to $1.23 billion in the same quarter last year. Gross profit increased 7.9% to $269 million, though gross margin contracted to 19% from 20.3% in the year-ago period.

"I am proud of the second quarter performance and the Option Care Health team’s ability to show resilience in a dynamic marketplace," said John C. Rademacher, Chief Executive Officer. "We continue to execute on opportunities to provide strong clinical outcomes while helping reduce the total cost of care."

The company’s adjusted EBITDA rose 5.2% to $114 million compared to $108.4 million in the second quarter of 2024. Cash flow from operations was $90.3 million, down from $195.7 million in the same period last year. The company also repurchased approximately $50 million of stock during the quarter.

Looking ahead, Option Care Health updated its full-year 2025 guidance, now expecting revenue between $5.5 billion and $5.65 billion, in line with the analyst consensus of $5.54 billion. The company forecasts adjusted EPS of $1.65 to $1.72, compared to the consensus estimate of $1.68, and adjusted EBITDA of $465 million to $475 million.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.